Gestational diabetes is more complex than we thought. From its unexpected link to fetal growth restriction, to cultural variations in prevalence, to promising new digital and behavioral interventions – this episode unpacks the latest evidence reshaping maternal care.

In this episode of Rethinking Diabetes: A Weekly Review, we explore the evolving science behind GLP-1 receptor agonists, early Type 1 diabetes detection, and the rising significance of liver and adipose tissue in metabolic disease. From surprising cancer risk patterns to breakthroughs in continuous glucose monitoring and nocturnal blood pressure research, we unpack the latest evidence shaping the future of diabetology.

Diabetic foot ulcers affect millions and cost healthcare systems billions — yet our standard treatments may be missing the mark. In this episode, we explore emerging research that's challenging everything from antibiotic use to patient education. You'll hear about bacteriophage therapy, vitamin D nanofibers, cutting-edge omics, and the overlooked impact of mental health and health literacy. Is this the turning point for diabetic wound care?

This episode of Rethinking Diabetes breaks down the newest evidence on once-weekly basal insulin, including data from five major trials and the surprising safety concerns that emerged. We explore real-world implications, from hypoglycemia risk to CGM-guided titration, and what it all means for patient selection, adherence, and the future of diabetes care.

We’ve long underestimated the pancreas — but new research reveals it's more than a digestive workhorse. From real-time hormone tracking and microRNA surprises to oxytocin’s metabolic role and age-defying molecules like taurine, this episode uncovers how the pancreas choreographs a complex interplay of aging, immunity, and energy regulation. Get ready for a deep dive into the science that's reshaping how we understand — and treat — metabolic disease.

This week on Rethinking Diabetes, we explore a major discovery linking low PAPP-A levels in early pregnancy to a 75% higher risk of gestational diabetes — and what that means for early intervention. From metabolic “vicious cycles” to cutting-edge assays and the post-COVID rise in complications, this episode connects the latest findings across reproductive health, immunology, and metabolic science to spotlight a more personalized future for diabetes care.